- Home
- CRDF vs ALLT Comparison
CRDF vs ALLT Comparison
Compare CRDF & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ALLT
- Stock Information
- Founded
- CRDF 1999
- ALLT 1996
- Country
- CRDF United States
- ALLT Israel
- Employees
- CRDF N/A
- ALLT N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ALLT Telecommunications Equipment
- Sector
- CRDF Health Care
- ALLT Telecommunications
- Exchange
- CRDF Nasdaq
- ALLT Nasdaq
- Market Cap
- CRDF 196.2M
- ALLT 229.8M
- IPO Year
- CRDF N/A
- ALLT 2006
- Fundamental
- Price
- CRDF $2.66
- ALLT $6.34
- Analyst Decision
- CRDF Strong Buy
- ALLT Buy
- Analyst Count
- CRDF 4
- ALLT 1
- Target Price
- CRDF $12.25
- ALLT $13.00
- AVG Volume (30 Days)
- CRDF 1.1M
- ALLT 227.3K
- Earning Date
- CRDF 05-08-2025
- ALLT 05-12-2025
- Dividend Yield
- CRDF N/A
- ALLT N/A
- EPS Growth
- CRDF N/A
- ALLT N/A
- EPS
- CRDF N/A
- ALLT N/A
- Revenue
- CRDF $587,000.00
- ALLT $92,195,000.00
- Revenue This Year
- CRDF N/A
- ALLT $6.43
- Revenue Next Year
- CRDF N/A
- ALLT $5.83
- P/E Ratio
- CRDF N/A
- ALLT N/A
- Revenue Growth
- CRDF N/A
- ALLT N/A
- 52 Week Low
- CRDF $2.01
- ALLT $2.02
- 52 Week High
- CRDF $5.64
- ALLT $9.44
- Technical
- Relative Strength Index (RSI)
- CRDF 42.40
- ALLT 58.17
- Support Level
- CRDF $2.42
- ALLT $5.61
- Resistance Level
- CRDF $2.87
- ALLT $6.32
- Average True Range (ATR)
- CRDF 0.19
- ALLT 0.31
- MACD
- CRDF 0.01
- ALLT 0.05
- Stochastic Oscillator
- CRDF 27.91
- ALLT 91.92
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.